Key Metrics
CiteScore 

4.6
Impact Factor 

< 5
SNIP 

1.15
Recommended pre-submission checks
Powered by 

Korean Journal of Internal Medicine Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | KOREAN ASSOC INTERNAL MEDICINE |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | USD 500 |
| Publication Time | 20 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | The Korean Association of Internal Medicine |
| Frequency | Bi-monthly |
| Publication Start Year | 1986 |
| Website URL | Visit website |
| Publication Details | |
| Publication Time | 20 |
| Waiver Policy | Visit website |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Korean Journal of Internal Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Korean Journal of Internal Medicine
The effect of HFE gene mutation and iron overload on sustained virological response in Egyptian chronic hepatitis C patients treated with daclatasvir and sofosbuvir
- 1 Mar 2026
- The Korean Journal of Internal Medicine
Clinical features of NAAT-positive, toxin-negative Clostridioides difficile infections in South Korea
- 1 Mar 2026
- The Korean Journal of Internal Medicine
Drug hypersensitivity leading to emergency department visit: a comprehensive analysis of clinical features and management
- 1 Mar 2026
- The Korean Journal of Internal Medicine
High diffuse bone marrow uptake in 18F-FDG PET/CT may reflect the diverse mutational characteristics of multiple myeloma
- 1 Mar 2026
- The Korean Journal of Internal Medicine
Hemodialysis vascular access infections: epidemiology and risk factors for treatment failure
- 1 Mar 2026
- The Korean Journal of Internal Medicine
Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphoma
- 1 Mar 2026
- The Korean Journal of Internal Medicine
The effect of HFE gene mutation and iron overload on sustained virological response in Egyptian chronic hepatitis C patients treated with daclatasvir and sofosbuvir
- 1 Mar 2026
- The Korean Journal of Internal Medicine
Clinical features of NAAT-positive, toxin-negative Clostridioides difficile infections in South Korea
- 1 Mar 2026
- The Korean Journal of Internal Medicine
Drug hypersensitivity leading to emergency department visit: a comprehensive analysis of clinical features and management
- 1 Mar 2026
- The Korean Journal of Internal Medicine
High diffuse bone marrow uptake in 18F-FDG PET/CT may reflect the diverse mutational characteristics of multiple myeloma
- 1 Mar 2026
- The Korean Journal of Internal Medicine
Hemodialysis vascular access infections: epidemiology and risk factors for treatment failure
- 1 Mar 2026
- The Korean Journal of Internal Medicine
Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphoma
- 1 Mar 2026
- The Korean Journal of Internal Medicine